Evaluation of the clinical utility of platelet aggregation studies

Keyphrases

• Abnormal Bleeding 40%
• Abnormal Pattern 20%
• Abnormal Response 20%
• Adult Patients 20%
• Aggregation Studies 100%
• Arachidonate 20%
• Aspirin 20%
• Bleeding 20%
• Bleeding Disorders 40%
• Bleeding History 20%
• Bleeding Time 40%
• Clinical Utility 100%
• Drug-induced 20%
• Efficient Utilization 20%
• Epinephrine 20%
• Family History 40%
• High Incidence 20%
• Hypercoagulability 20%
• Myeloproliferative Neoplasms 60%
• Patient Demographics 20%
• Platelet Aggregation 100%
• Platelet Aggregation Tests 100%
• Platelet Function Disorders 20%
• Poor Response 20%
• Retrospective Review 20%
• Spontaneous Aggregation 20%
• Storage Pool Deficiency 20%
• Tertiary Care Hospital 20%
• Test Abnormality 20%
• Thrombocytosis 40%
• Wave Response 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Acetylsalicylic Acid 33%
• Arachidonic Acid 33%
• Bleeding 100%
• Bleeding Disorder 66%
• Disease 100%
• Epinephrine 33%
• Hypercoagulability 33%
• Myeloproliferative Disorder 100%
• Thrombocytosis 66%

Medicine and Dentistry

• Acetylsalicylic Acid 14%
• Arachidonic Acid 14%
• Bleeding 42%
• Bleeding Disorder 28%
• Bleeding Time 28%
• Diagnosis 14%
• Disease 42%
• Epinephrine 14%
• Family History 28%
• Hypercoagulability 14%
• Myeloproliferative Disorder 42%
• Patient Population 14%
• Tertiary Care 14%
• Thrombocyte Aggregation 100%
• Thrombocyte Function 14%
• Thrombocytosis 28%